Express News | Intensity Therapeutics Shares Are Trading Lower. The Company Presented Final Data From Intensity's INVINCIBLE-2 Study and an Overview/update of the INVINCIBLE-4 Study

Benzinga34minutes ago

Intensity Therapeutics Shares Are Trading Lower. The Company Presented Final Data From Intensity's INVINCIBLE-2 Study and an Overview/update of the INVINCIBLE-4 Study.

Benzinga34minutes ago

Intensity Therapeutics Says Cancer Drug Candidate Shows Benefits in Phase 2 Trial

MT Newswires11:26 ET

Intensity Therapeutics Reports Positive Results of INT230-6 in Breast Cancer

TipRanksDec 12 08:10 ET

Express News | Intensity Therapeutics And The Swiss Group For Clinical Cancer Research SAKK Highlight Dec. 11 Presentation Of Phase 2 Breast Cancer Data From Completed INVINCIBLE-2 Study At 2024 San Antonio Breast Cancer Symposium

BenzingaDec 12 08:05 ET

Intensity Therapeutics Analyst Ratings

BenzingaNov 21 12:59 ET · Ratings